A key therapeutic strategy to treat neurodegenerative diseases would thereby involve finding a means to interfere with the pathological activity of Cdk5 by blocking its interaction with p25 while still maintaining its normal neuronal functions when complexed to p35. Here, CDK5 is linked to neurodegenerative disease.